MARKET

PAHC

PAHC

Phibro Animl
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.07
+0.07
+0.27%
After Hours: 26.07 0 0.00% 16:00 07/02 EDT
OPEN
26.44
PREV CLOSE
26.00
HIGH
26.66
LOW
25.95
VOLUME
92.58K
TURNOVER
--
52 WEEK HIGH
33.97
52 WEEK LOW
16.87
MARKET CAP
1.05B
P/E (TTM)
28.77
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PAHC stock price target is 22.50 with a high estimate of 25.00 and a low estimate of 18.00.

EPS

PAHC News

More
Do Hedge Funds Love Phibro Animal Health Corp (PAHC)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 6d ago
Edited Transcript of PAHC earnings conference call or presentation 8-May-20 1:00pm GMT
Q3 2020 Phibro Animal Health Corp Earnings Call
Thomson Reuters StreetEvents · 06/04 01:58
3 Pet Med Stocks That Offer Growth and a Nice Dividend
Spending on pet health continues to climb. Investors should consider buying PetMed Express, Phibro Animal Health, and Merck & Co.
Motley Fool · 06/02 15:33
Phibro (PAHC) Q3 Earnings Surpass Estimates, Margin Declines
Zacks · 05/13 15:09
Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/08 19:50
Credit Suisse Maintains Neutral on Phibro Animal Health, Lowers Price Target to $23
Credit Suisse maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $25 to $23.
Benzinga · 05/08 14:45
Phibro Animal Health Corporation Reports Third Quarter Results
Business Wire · 05/07 21:40
Phibro Animal Health Q3 Adj. EPS $0.380 Beats $0.340 Estimate, Sales $211.000M Beat $208.270M Estimate
Phibro Animal Health (NASDAQ:PAHC) reported quarterly earnings of $0.380 per share which beat the analyst consensus estimate of $0.340 by 11.76 percent. This is a 2.56 percent decrease over earnings of $0.390 per share
Benzinga · 05/07 21:35

Industry

Pharmaceuticals
+0.58%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About PAHC

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
More

Webull offers kinds of Phibro Animal Health Corp stock information, including NASDAQ:PAHC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAHC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAHC stock methods without spending real money on the virtual paper trading platform.